We are live on ! Find out more
MS

Maven Securities Portfolio holdings

AUM $5.2B
1-Year Est. Return 44.01%
This Fund
S&P 500
This Quarter Est. Return
+10.61%
1 Year Est. Return
+44.01%
3 Year Est. Return
+102.83%
5 Year Est. Return
+136.18%
10 Year Est. Return
AUM
$2.23B
AUM Growth
+$1.22B
Cap. Flow
+$1.34B
Cap. Flow %
60.06%
Top 10 Hldgs %
26.38%
Holding
1,418
New
876
Increased
102
Reduced
142
Closed
269

Top Buys

Rank Stock Value
1
QQQ icon
Invesco QQQ Trust
QQQ
+$22.4M
2
QS icon
QuantumScape Corp
QS
+$15.9M
3
MP icon
MP Materials
MP
+$13.9M
4
RP
RealPage, Inc.
RP
+$13.5M
5
GPRE icon
Green Plains
GPRE
+$12.3M

Sector Composition

Rank Sector Weight
1 Healthcare 12.71%
2 Industrials 5%
3 Consumer Discretionary 4.69%
4 Technology 4.51%
5 Financials 4.4%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VBIV
1326
DELISTED
VBI Vaccines, Inc. New Common Stock (Canada)
VBIV
-10,960
Closed -$993K
COOLU
1327
DELISTED
Corner Growth Acquisition Corp. Unit
COOLU
-100,000
Closed -$1.05M
PXD
1328
DELISTED
Pioneer Natural Resource Co.
PXD
-17,955
Closed -$2.55M
NGM
1329
DELISTED
NGM Biopharmaceuticals, Inc. Common Stock
NGM
-33,728
Closed -$1.04M
KNTE
1330
DELISTED
Kinnate Biopharma Inc. Common Stock
KNTE
-5,952
Closed -$237K
VIEW
1331
DELISTED
View, Inc. Class A Common Stock
VIEW
-5,554
Closed -$3.79M
MRTX
1332
DELISTED
Mirati Therapeutics, Inc. Common Stock
MRTX
-28,900
Closed -$6.35M
LVOX
1333
DELISTED
LiveVox Holding, Inc. Class A Common Stock
LVOX
-138,741
Closed -$1.46M
MDWT
1334
DELISTED
Midwest Holding Inc. Common Stock
MDWT
-11,863
Closed -$676K
MCOM
1335
DELISTED
micromobility.com Inc. Class A Common stock
MCOM
-3
Closed -$258K
BTWNU
1336
DELISTED
Bridgetown Holdings Limited Units
BTWNU
-50,000
Closed -$881K
CELL
1337
DELISTED
PhenomeX Inc. Common Stock
CELL
-32,912
Closed -$3.03M
TRTN
1338
DELISTED
Triton International Limited
TRTN
-21,877
Closed -$1.06M
NUVA
1339
DELISTED
NuVasive, Inc.
NUVA
-88,903
Closed -$5.06M
AMRS
1340
DELISTED
Amyris Inc.
AMRS
-200,000
Closed -$1.31M
PTRA
1341
DELISTED
Proterra Inc. Common Stock
PTRA
-85,000
Closed -$963K
NMTR
1342
DELISTED
9 Meters Biopharma
NMTR
-37,500
Closed -$667K
TCRR
1343
DELISTED
TCR2 Therapeutics Inc. Common Stock
TCRR
-35,284
Closed -$1.09M
SGTX
1344
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
-409
Closed -$255K
MAXR
1345
DELISTED
Maxar Technologies Inc. Common Stock
MAXR
-10,000
Closed -$390K
CSII
1346
DELISTED
Cardiovascular Systems, Inc.
CSII
-30,000
Closed -$1.31M
ML
1347
DELISTED
MoneyLion Inc.
ML
-2,883
Closed -$979K
SIOX
1348
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
-86,788
Closed -$246K
ALBO
1349
DELISTED
Albireo Pharma Inc
ALBO
-10,000
Closed -$382K
AVYA
1350
DELISTED
Avaya Holdings Corp. Common Stock
AVYA
-15,000
Closed -$287K

Similar funds

Maven Securities's Q1 2021 Portfolio in Review

As of Q1 2021, Maven Securities held 1,418 positions worth $2.23B, up 121% from $1.01B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Maven Securities deployed $1.34B of net new capital in Q1 2021, opening 876 new positions and adding to 102 existing holdings. Its largest new stake was QuantumScape Corp: 303,111 shares worth $13.5M.

By sector, the portfolio is most concentrated in Healthcare at 13% of assets, down from 32% a quarter earlier, followed by Industrials and Consumer Discretionary.

On the sell side, the largest reduction was AdaptHealth, an estimated $18.2M trimmed.

  • Maven Securities's largest Q1 2021 buy was QuantumScape Corp: 303,111 shares worth $13.5M.
  • Maven Securities added most to Invesco QQQ Trust in Q1 2021, an estimated $22.4M increase.
  • Maven Securities's biggest Q1 2021 reduction was AdaptHealth, cutting an estimated $18.2M.
  • Maven Securities fully exited Adaptive Biotechnologies in Q1 2021, selling an estimated $25.6M.
  • Maven Securities's ten largest holdings make up 26% of its $2.23B portfolio in Q1 2021.
  • Maven Securities opened 876 new positions and closed 269 in Q1 2021.
  • Maven Securities's portfolio value rose 121% quarter-over-quarter to $2.23B.

Based on Maven Securities's 13F filing for Q1 2021, filed 17 May 2021.